# Maintenance Treatment of Iron Deficiency in IBD Patients

> **NCT00810004** · PHASE3 · COMPLETED · sponsor: **Vifor Pharma** · enrollment: 245 (actual)

## Conditions studied

- Iron Deficiency
- Inflammatory Bowel Disease

## Interventions

- **DRUG:** Ferinject

## Key facts

- **NCT ID:** NCT00810004
- **Lead sponsor:** Vifor Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 245 (ACTUAL)
- **Last updated:** 2012-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00810004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00810004, "Maintenance Treatment of Iron Deficiency in IBD Patients". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00810004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*